ArticleIn vivo (Athens, Greece)

Co-clinical Modeling of the Activity of the BET Inhibitor Mivebresib (ABBV-075) in AML.

Daniel H Albert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.